Contemporary cancer treatment has witnessed unprecedented advancement through molecular biomarker integration, establishing the Mismatch Repair Deficiency Market as a pivotal component of precision oncology evolution. Mismatch repair deficiency (dMMR) functions as a fundamental cellular biomarker indicating compromised DNA quality control mechanisms that normally prevent genetic errors during...